AU2003252315A1 - 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof - Google Patents

4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof

Info

Publication number
AU2003252315A1
AU2003252315A1 AU2003252315A AU2003252315A AU2003252315A1 AU 2003252315 A1 AU2003252315 A1 AU 2003252315A1 AU 2003252315 A AU2003252315 A AU 2003252315A AU 2003252315 A AU2003252315 A AU 2003252315A AU 2003252315 A1 AU2003252315 A1 AU 2003252315A1
Authority
AU
Australia
Prior art keywords
quinoline
substituted
addition salts
pharmacologically acceptable
acceptable addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003252315A
Inventor
Tsuyoshi Anraku
Jyunichi Ishiyama
Futoshi Shiga
Yasuo Takano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of AU2003252315A1 publication Critical patent/AU2003252315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2003252315A 2002-08-09 2003-08-01 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof Abandoned AU2003252315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-232295 2002-08-09
JP2002232295 2002-08-09
PCT/JP2003/009790 WO2004014861A1 (en) 2002-08-09 2003-08-01 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof

Publications (1)

Publication Number Publication Date
AU2003252315A1 true AU2003252315A1 (en) 2004-02-25

Family

ID=31711823

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003252315A Abandoned AU2003252315A1 (en) 2002-08-09 2003-08-01 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof

Country Status (3)

Country Link
JP (1) JPWO2004014861A1 (en)
AU (1) AU2003252315A1 (en)
WO (1) WO2004014861A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4306505B2 (en) * 2004-03-22 2009-08-05 三菱自動車エンジニアリング株式会社 Door sash reinforcement structure
EP1746092A1 (en) * 2005-07-22 2007-01-24 Exonhit Therapeutics SA Compounds and methods for treatment of amyloid-B-peptide related disorders
AU2008204380B2 (en) 2007-01-10 2013-08-15 Msd Italia S.R.L. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
CN101932572A (en) 2008-01-08 2010-12-29 默沙东有限公司 2-{4-[(3S)-and piperidines-3-yl] phenyl }-pharmacologically acceptable salts of 2H-indazole-7-carboxylic acid amides
ES2729754T3 (en) 2010-07-29 2019-11-06 Merck Patent Gmbh Azaheterocyclic carboxyamides of cyclic amines
UA110113C2 (en) * 2010-07-29 2015-11-25 BICYCLIC AZAGETEROCYCLIC CARBOXAMIDES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3917233A1 (en) * 1989-05-26 1990-11-29 Basf Ag 8-SUBSTITUTED 4- (HETEROCYCLYLMETHYLAMINO) -INCHINOLINES, THEIR USE AND DRUGS DERIVED THEREFROM
US6635642B1 (en) * 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
JP2002515488A (en) * 1998-05-15 2002-05-28 ギルフォード ファーマシューティカルズ インコーポレイテッド Carboxamide compounds, compositions, and methods for inhibiting PARP activity

Also Published As

Publication number Publication date
WO2004014861A1 (en) 2004-02-19
JPWO2004014861A1 (en) 2005-12-02

Similar Documents

Publication Publication Date Title
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
AU2003227360A1 (en) Novel amide derivatives or salts thereof
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
IL165923A0 (en) New quinuclidine amide derivatives
IL165177A0 (en) Azulene derivatives and salts thereof
AU2003255492A1 (en) Heterocyclic derivatives
AU2003220935A1 (en) Benzamide derivatives
IL175953A (en) 3-cycloalkylaminopyrrolidine derivatives, pharmaceutically acceptable salts thereof and compositions comprising the same
AU2003261974A1 (en) Amine compounds and use thereof
AU2003241833A1 (en) Beta-ALANINE DERIVATIVE AND USE THEREOF
EG25683A (en) Benzoxazine derivatives and uses thereof
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003228825A1 (en) Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003252314A1 (en) 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003252315A1 (en) 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof
AU2003231370A1 (en) Amide derivatives
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003235889A1 (en) Amide derivatives
AU2003227517A1 (en) Pharmacologically active salts

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase